Shots: The P-III IMpassion031 study involves assessing of Tecentriq + CT (Abraxane, nab-paclitaxel; followed by doxorubicin and cyclophosphamide) vs PBO + CT in 333 people in a ratio (1:1) with […]readmore
Tags : IMpassion031